Literature DB >> 28838785

External Validation of a Thiopurine Monitoring Algorithm on the SONIC Clinical Trial Dataset.

Akbar K Waljee1, Kay Sauder2, Yiwei Zhang3, Ji Zhu3, Peter D R Higgins2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28838785      PMCID: PMC5816686          DOI: 10.1016/j.cgh.2017.08.021

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


× No keyword cloud information.
  8 in total

1.  Machine learning in medicine: a primer for physicians.

Authors:  Akbar K Waljee; Peter D R Higgins
Journal:  Am J Gastroenterol       Date:  2010-06       Impact factor: 10.864

2.  Bridging the Data-Sharing Divide - Seeing the Devil in the Details, Not the Other Camp.

Authors:  Lisa Rosenbaum
Journal:  N Engl J Med       Date:  2017-04-26       Impact factor: 91.245

3.  Infliximab, azathioprine, or combination therapy for Crohn's disease.

Authors:  Jean Frédéric Colombel; William J Sandborn; Walter Reinisch; Gerassimos J Mantzaris; Asher Kornbluth; Daniel Rachmilewitz; Simon Lichtiger; Geert D'Haens; Robert H Diamond; Delma L Broussard; Kezhen L Tang; C Janneke van der Woude; Paul Rutgeerts
Journal:  N Engl J Med       Date:  2010-04-15       Impact factor: 91.245

4.  Association of 6-thioguanine nucleotide levels and inflammatory bowel disease activity: a meta-analysis.

Authors:  Mark T Osterman; Rabi Kundu; Gary R Lichtenstein; James D Lewis
Journal:  Gastroenterology       Date:  2006-04       Impact factor: 22.682

5.  Algorithms outperform metabolite tests in predicting response of patients with inflammatory bowel disease to thiopurines.

Authors:  Akbar K Waljee; Joel C Joyce; Sijian Wang; Aditi Saxena; Margaret Hart; Ji Zhu; Peter D R Higgins
Journal:  Clin Gastroenterol Hepatol       Date:  2009-10-14       Impact factor: 11.382

6.  6-thioguanine nucleotide-adapted azathioprine therapy does not lead to higher remission rates than standard therapy in chronic active crohn disease: results from a randomized, controlled, open trial.

Authors:  Max Reinshagen; Ekkehard Schütz; Victor W Armstrong; Christoph Behrens; Christian von Tirpitz; Andreas Stallmach; Hans Herfarth; Jürgen Stein; Peter Bias; Guido Adler; Maria Shipkova; Wolfgang Kruis; Michael Oellerich; Nicolas von Ahsen
Journal:  Clin Chem       Date:  2007-05-10       Impact factor: 8.327

7.  Randomised clinical trial: individualised vs. weight-based dosing of azathioprine in Crohn's disease.

Authors:  T Dassopoulos; M C Dubinsky; J L Bentsen; C F Martin; J A Galanko; E G Seidman; R S Sandler; S B Hanauer
Journal:  Aliment Pharmacol Ther       Date:  2013-11-17       Impact factor: 8.171

8.  Machine Learning Algorithms for Objective Remission and Clinical Outcomes with Thiopurines.

Authors:  Akbar K Waljee; Kay Sauder; Anand Patel; Sandeep Segar; Boang Liu; Yiwei Zhang; Ji Zhu; Ryan W Stidham; Ulysses Balis; Peter D R Higgins
Journal:  J Crohns Colitis       Date:  2017-07-01       Impact factor: 9.071

  8 in total
  3 in total

1.  Response to 'The end of the dosage of 6 Thioguanine nucleotides? Not so sure…'.

Authors:  Akbar K Waljee; Kay Sauder; Anand Patel; Sandeep Segar; Yiwei Zhang; Ji Zhu; Ryan W Stidham; Ulysses Balis; Peter D R Higgins
Journal:  J Crohns Colitis       Date:  2018-01-05       Impact factor: 9.071

Review 2.  Artificial Intelligence for Disease Assessment in Inflammatory Bowel Disease: How Will it Change Our Practice?

Authors:  Ryan W Stidham; Kento Takenaka
Journal:  Gastroenterology       Date:  2022-01-04       Impact factor: 22.682

3.  Clinical applications of artificial intelligence and machine learning-based methods in inflammatory bowel disease.

Authors:  Shirley Cohen-Mekelburg; Sameer Berry; Ryan W Stidham; Ji Zhu; Akbar K Waljee
Journal:  J Gastroenterol Hepatol       Date:  2021-02       Impact factor: 4.029

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.